Kathryn J. Collier - 16 Jun 2025 Form 4 Insider Report for Regulus Therapeutics Inc. (RGLS)

Role
Director
Signature
Christopher Aker, Attorney in Fact
Issuer symbol
RGLS
Transactions as of
16 Jun 2025
Net transactions value
+$60,060
Form type
4
Filing time
18 Jun 2025, 17:00:04 UTC
Previous filing
30 Apr 2025
Next filing
27 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Collier Kathryn J Director C/O REGULUS THERAPEUTICS, 4224 CAMPUS POINT COURT #210, SAN DIEGO Christopher Aker, Attorney in Fact 18 Jun 2025 0001737436

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGLS Common Stock Options Exercise $13,820 +1,396 +2.1% $9.90 67,844 16 Jun 2025 Direct
transaction RGLS Common Stock Options Exercise $25,780 +2,604 +4.2% $9.90 65,240 17 Jun 2025 Direct
transaction RGLS Common Stock Options Exercise $20,460 +2,325 +3.8% $8.80 62,915 17 Jun 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGLS Stock Option (Right to Buy) Options Exercise $0 -1,396 -35% $0.000000 2,604 16 Jun 2025 Common Stock 1,396 $9.90 Direct
transaction RGLS Stock Option (Right to Buy) Options Exercise $0 -2,604 -100% $0.000000 0 17 Jun 2025 Common Stock 2,604 $9.90 Direct
transaction RGLS Stock Option (Right to Buy) Options Exercise $0 -2,325 -100% $0.000000 0 17 Jun 2025 Common Stock 2,325 $8.80 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.